We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

264 hedge funds and large institutions have $591M invested in Editas Medicine in 2022 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 73 increasing their positions, 75 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 28

27% more call options, than puts

Call options by funds: $23.8M | Put options by funds: $18.6M

5% more capital invested

Capital invested by funds: $561M → $591M (+$30.3M)

3% more funds holding

Funds holding: 256 → 264 (+8)

1.05% more ownership

Funds ownership: 69.17% → 70.22% (+1%)

3% less repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 75

Holders
264
Holders Change
+8
Holders Change %
+3.13%
% of All Funds
4.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
73
Reduced
75
Closed
28
Calls
$23.8M
Puts
$18.6M
Net Calls
+$5.13M
Net Calls Change
+$6.09M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$27M
2
PHS
PFM Health Sciences
California
+$10.1M
3
Goldman Sachs
Goldman Sachs
New York
+$5.11M
4
Two Sigma Investments
Two Sigma Investments
New York
+$4.89M
5
Man Group
Man Group
United Kingdom
+$4.82M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$23.9M
2
WP
Woodline Partners
California
-$12M
3
NAMA
Nikko Asset Management Americas
New York
-$6.12M
4
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
-$6.12M
5
Citadel Advisors
Citadel Advisors
Florida
-$5.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
PP
51
PDT Partners
New York
$1.53M +$589K +37,793 +43%
Jane Street
52
Jane Street
New York
$1.5M -$101K -6,505 -5%
Walleye Capital
53
Walleye Capital
New York
$1.38M +$1.76M +112,980 New
RhumbLine Advisers
54
RhumbLine Advisers
Massachusetts
$1.33M +$115K +7,354 +7%
Jacobs Levy Equity Management
55
Jacobs Levy Equity Management
New Jersey
$1.31M +$1.67M +107,138 New
Parallax Volatility Advisers
56
Parallax Volatility Advisers
California
$1.19M +$147K +9,415 +11%
Commonwealth Equity Services
57
Commonwealth Equity Services
Massachusetts
$1.15M -$97.2K -6,241 -6%
Stifel Financial
58
Stifel Financial
Missouri
$1.14M +$42.1K +2,705 +3%
UBS Group
59
UBS Group
Switzerland
$1.09M -$2.99M -191,963 -68%
California State Teachers Retirement System (CalSTRS)
60
California State Teachers Retirement System (CalSTRS)
California
$1.06M -$20.1K -1,290 -1%
RJA
61
Raymond James & Associates
Florida
$1.05M -$819K -52,571 -38%
Balyasny Asset Management
62
Balyasny Asset Management
Illinois
$1.04M -$3.57M -229,044 -73%
ABG
63
Ally Bridge Group
New York
$1.01M +$1.29M +82,900 New
AllianceBernstein
64
AllianceBernstein
Tennessee
$1.01M – – –
TC
65
TwinBeech Capital
New York
$991K +$1.26M +80,974 New
CAM
66
Congress Asset Management
Massachusetts
$980K +$15.6K +1,004 +1%
IMC Chicago
67
IMC Chicago
Illinois
$969K -$69.8K -4,480 -5%
FAIM
68
Financial Advocates Investment Management
Washington
$943K +$123K +7,882 New
Royal Bank of Canada
69
Royal Bank of Canada
Ontario, Canada
$935K +$33.6K +2,154 +3%
Deutsche Bank
70
Deutsche Bank
Germany
$929K -$686 -44 -0.1%
TYCC
71
Texas Yale Capital Corp
Florida
$857K – – –
JF
72
Jump Financial
Illinois
$821K -$28.8K -1,851 -3%
Cambridge Investment Research Advisors
73
Cambridge Investment Research Advisors
Iowa
$814K +$18.1K +1,159 +2%
UBS AM
74
UBS AM
Illinois
$759K +$161K +10,347 +20%
Legal & General Group
75
Legal & General Group
United Kingdom
$750K -$1.51M -96,794 -61%
1 2
3
4 5

EDIT Hedge Fund Activity: Q3 2022 in Review

264 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2022, worth a combined $591M — up 5.4% from $561M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new EDIT positions and 28 closed out — a net gain of 11 holders — while 73 added to existing stakes and 75 trimmed.

The largest buyer was Millennium Management, adding an estimated $27M. The largest seller was State Street, cutting an estimated $23.9M.

  • 264 institutional investors held Editas Medicine (EDIT) as of Q3 2022, up from 256 in Q2 2022.
  • Funds reported $591M of Editas Medicine stock for Q3 2022, up 5.4% quarter-over-quarter.
  • 39 funds opened new Editas Medicine positions in Q3 2022 and 28 closed out, a net change of +11 holders.
  • The largest Editas Medicine buyer in Q3 2022 was Millennium Management, an estimated $27M added.
  • The largest Editas Medicine seller in Q3 2022 was State Street, an estimated $23.9M sold.

Based on aggregated 13F filings for Q3 2022.